PREGNANCY IN WOMEN WITH CHRONIC KIDNEY DISEASE OF ALL STAGES, INCLUDING WOMEN ON DIALYSIS AND WITH KIDNEY TRANSPLANTS
With
Professor Shilpanjali Jesudason
Head of Unit, Central and Northern Adelaide Renal and Transplantation Service (CNARTS),
Royal Adelaide Hospital,
Central Adelaide Local Health Network (CALHN) &
Clinical Professor, University of Adelaide, South Australia
RESEARCHER PROFILE
Filmed in Adelaide, South Australia | March 2025
Professor Shilpanjali Jesudason is an academic nephrologist and Head of Department at the Royal Adelaide Hospital’s Central Northern Adelaide Renal and Transplant Service, South Australia.
From 2017-2020, she was the Clinical Director of Kidney Health Australia, the peak body for patients with kidney disease. In this role she developed a passion for advancing kidney disease education in primary care.
She is the founder and Program Lead for Pregnancy and Kidney Research Australia, co-leads the new ISN Train the Trainer Program for Pregnancy and Kidney Disease, and is the inaugural chair of the Australian and Zealand Dialysis and Transplantation Registry (ANZDATA) Parenthood working group.
She is founding chair of the ANZ Society of Nephrology Pacific Working Group, and has been a supporter of nephrology development in her birth country of Fiji.
In 2025, she was awarded the Roscoe R. Robinson award for outstanding contributions to nephrology, by the International Society of Nephrology.
https://orcid.org/0000-0001-9695-0761
-
Prescribing exercise to regional population with cardiovascular disease & diabetes
Associate Professor Gordon’s research is aimed at determining the optimal methods of prescribing and implementing exercise as part of the health care plan for people with cardiovascular disease and diabetes. Specifically, he is leading work to determine if and how the components of exercise can be considered as a whole for prescribing exercise to generate health benefits. This is important to overcome the series of barriers that people living in rural and regional areas experience when trying to become active.
-
Impact of Leukaemia Foundation’s Research Funding into Blood Cancer
Bill Stavreski is the Head of Research at the Leukaemia Foundation who talks about the research impact in recent years. The Foundation itself marks its 25th anniversary in 2025, having funded a wide range of health and medical research since 2000. With a focus on basic science, health services research, treatment, and care, the organisation has invested nearly $90 million (adjusted in current dollars terms) in approximately 370 research grants over the years.
-
Next generation nanomedicine and radiopharmaceuticals to treat cancer
Finding better ways of treating cancer, aside from finding a cure, aim to provide a better quality of life for those who suffer from it.
Professor Thurecht’s work focuses on nanomedicine and spans across the Australian Institute for Bioengineering and Nanotechnology and the Centre for Advanced Imaging, at the University of Queensland in Australia.
